Context: GH treatment is approved for short children born small for gestational age (SGA).
The optimal dose is not yet established. Objective: Our objective was to develop a model for …

Objectives. Information on the efficacy of GH treatment in short SGA children starting their
treatment in adolescence is limited. Therefore, adult height (AH), total height gain, and …

Context Growth hormone (GH) is used to treat short children born small for gestational age
(SGA); however, the effects of treatment on pubertal timing and adult height are rarely …

Objective Initial GH-induced catch up growth is highly variable in short children born small
for gestational age (SGA) and mainly influenced by age at start of therapy and GH dose. This …

Context: Children born small for gestational age (SGA) with poor growth during the first
years of life may remain short in stature during childhood and as adults. Objective: To …

The aim of this observational study was to assess the long-term growth responses to GH
treatment of children born small for gestational age (SGA). GH treatment was begun before …

The efficacy of GH for increasing adult height (AH) in short adolescents born small for
gestational age (SGA) is unclear, due to the lack of long-term controlled trials. A total of 168 …

Context: Several studies have searched for factors that significantly influence adult height
(AH) of children with GH deficiency (GHD) who have been treated with biosynthetic GH, but …

Context: GH treatment is effective in improving height in short children born small for
gestational age (SGA). GH is thought to have limited effect when started during …

Context: Children born prematurely with growth failure might benefit from GH treatment.
Objectives: The aim was to evaluate the first year growth response to GH treatment in short …